3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Prostatic Neoplasms
5
Ovarian Neoplasms
4
Breast Neoplasms
4
Pancreatic Neoplasms
3
Colorectal Neoplasms, Hereditary Nonpolyposis
3
Triple Negative Breast Neoplasms
2
Neoplastic Syndromes, Hereditary
2
Hereditary Breast and Ovarian Cancer Syndrome
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Sarcoma
1
Rectal Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Lymphoproliferative Disorders
1
Kidney Neoplasms
1
Hematologic Neoplasms
1
Fanconi Anemia, Complementation Group D1
1
Cytopenia
1
Congenital Bone Marrow Failure Syndromes
1
Colonic Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Intraductal, Noninfiltrating
1
Cancer Risk Syndrome
1
Breast Neoplasms, Male
1
Bone Marrow Failure Disorders
1
Advanced Malignant Neoplasm
1
Interventions
Sunitinib
5
Radiosurgery
5
Blood Specimen Collection
4
Surgical Procedures, Operative
3
fludarabine phosphate
2
Surveys and Questionnaires
2
Robotic Surgical Procedures
2
Peripheral Blood Stem Cell Transplantation
2
Methods
2
Magnetic Resonance Spectroscopy
2
Exercise
2
Cyclophosphamide
2
Cryosurgery
2
temsirolimus
1
salicylhydroxamic acid
1
perflutren
1
pazopanib
1
erythromycin propionate-N-acetylcysteinate
1
Watchful Waiting
1
Warm Ischemia
1
Varenicline
1
Urination
1
Ultrasonography, Doppler
1
Ultrasonography
1
Tyrosine Kinase Inhibitors
1
Tumor Burden
1
Traumeel S
1
Therapeutics
1
Tacrolimus
1
Surgery, Computer-Assisted
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Kidney Neoplasms
×
Genetic Counseling
×
Clear all
NCT05225428
2026-05-22
VERDI
Dana-Farber Cancer Institute
Phase NA
Recruiting
1,020 enrolled